Israel’s Stimatix to Compete in $2 Billion Stoma Market

Stimatix GI Ltd., whose product is designed to give stoma patients control over when they defecate, is seeking a partner to help the company compete in a $2 billion market controlled by three companies including Denmark’s Coloplast A/S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.